Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2022

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations

The carrying values of the major classes of assets and liabilities included in assets and liabilities held for sale related to Trans Ova as of December 31, 2021 are as follows:

	December 31,
	2021
Assets
Cash and cash equivalents	$	6,497
Trade Receivables, net	19,491
Inventory	12,935
Other current assets	1,265
Property, plan and equipment, net	25,716
Intangible assets, net	1,824
Goodwill	16,594
Right-of-use assets	910
Other noncurrent assets	252
Total assets held for sale	$	85,484
Liabilities
Accounts payable	$	2,293
Accrued compensation and benefits	3,367
Other accrued liabilities	3,778
Deferred revenue	2,952
Current portion of long-term debt	350
Other current liabilities	111
Long-term debt, net of current portion	2,867
Other long-term liabilities	805
Total liabilities held for sale or abandonment	$	16,523

The following table presents the financial results of discontinued operations related to TransOva through the date of disposition in 2022:

	Year Ended December 31,
	2022		2021		2020
Product revenues	$	21,494	$	25,131	$	21,914
Service revenues	49,657		64,475		49,272
Total revenues	71,151		89,606		71,186
Cost of products	18,634		23,070		26,529
Cost of services	22,701		29,570		23,610
Research and development	2,348		2,208		2,216
Selling, general and administrative	15,215		22,128		19,010
Impairment of assets	—		—		106
Total operating expenses	58,898		76,976		71,471
Operating income (loss)	12,253		12,630		(285)
Other income, net	1,139		1,412		1,489
Equity in net loss of affiliates	—		—		(535)
Gain on divestiture	94,702		—		—
Income before income taxes	$	108,094	$	14,042	$	669
Income tax (expense) benefit	—		—		—
Income from discontinued operations	$	108,094	$	14,042	$	669

The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to Trans Ova that are included in the accompanying consolidated statements of cash flows:

	Year Ended December 31,
	2022	2021	2020
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	3,574	5,622	6,750
Impairment of assets	—	—	106
Loss on disposal of assets	421	561	4,325
Equity in net loss of affiliates	—	—	535
Provision for credit losses	944	1,128	899
Stock-based compensation expense	9	350	738
Cash flows from investing activities
Proceeds from repayment of notes receivable	—	3,689	—
Purchases of property, plant and equipment	(3,529)	(4,694)	(6,365)
Proceeds from sales of assets	594	1,894	2,387

The following table presents the financial results of discontinued operations related to MBP Titan:

	Year Ended December 31,
		2021		2020
Operating (gains) expenses (1)		$	(4,599)	$	40,692
Operating income (loss)		4,599		(40,692)
Income (loss) before income taxes		4,599		(40,692)
Income (loss) from discontinued operations		$	4,599	$	(40,692)

(1)Includes an impairment charge of $9,635 and an impairment charge on property, plant and equipment and ROU Assets of $12,406 in 2020 in conjunction with the suspension of MBP Titan's operations discussed above.

The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan that are included in the accompanying consolidated statements of cash flows.

	Year Ended December 31,
	2021		2020
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	$	—	2,474
Impairment of goodwill	—		9,635
Impairment of other noncurrent assets	—		12,406
(Gain) loss on disposal of assets, net	(464)		67
Stock-based compensation expense	—		(34)
Noncash gain on termination of leases	(4,602)		—
Cash flows from investing activities
Purchases of property, plant and equipment	—		(88)
Proceeds from sales of assets	1,083		3,952

The following tables present the financial results of discontinued operations related to the Transactions for the year ended December 31, 2020.

	Year Ended December 31, 2020
	TS Biotechnology Sale		EnviroFlight Sale		Total
Revenues (1)	$	1,294	$	—	$	1,294
Operating expenses	896		—		896
Operating income	398		—		398
Gain on sale of discontinued operations	633		39		672
Loss on release of cumulative foreign currency translation adjustment	(26,957)		—		(26,957)
Other expense, net	(129)		—		(129)
Equity in net loss of affiliates	—		(38)		(38)
Income (loss) before income taxes	(26,055)		1		(26,054)
Income tax expense	(2)		—		(2)
Income (loss) from discontinued operations	$	(26,057)	$	1	$	(26,056)

(1)Includes revenue recognized from related parties of $436.

The following table presents the significant noncash items, investments in EnviroFlight and purchases of property, plant and equipment for the discontinued operations for the Transactions that are included in the accompanying consolidated statements of cash flows.

	Year Ended December 31,
	2020
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	$	—
Impairment of goodwill	—
Impairment of other noncurrent assets	—
Gain on sale of discontinued operations	(672)
Loss on release of cumulative foreign currency translation adjustment	26,957
Unrealized and realized depreciation on equity securities and preferred stock, net	106
Equity in net loss of EnviroFlight	38
Stock-based compensation expense	(1,346)
Deferred income taxes	—
Cash flows from investing activities
Investments in EnviroFlight	—
Purchases of property, plant and equipment	(382)